GL1X · GenesisL1 explorer

Research workbench

Crystal structure of P38 alpha MAP kinase in complex with a novel isoform selective drug candidate

Analyse Crystal structure of P38 alpha MAP kinase in complex with a novel isoform… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4R3C
Type
protein
Length
336 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.11.24
UniProt
Q16539
Ligands
3GF, GG5, CL
Pockets
5 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.11.24)protein33643% helix, 16% strandQ16539

Ligands and binding sites

  • 3GF · 6-(4-methylpiperazin-1-yl)-3-(naphthalen-2-yl)-4-(pyridin-4-yl)pyridazine · ligand · 2 copies · chains A
  • GG5 · 4-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]pyridine · ligand · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14890.680.79483GF, CL
21100.680.9020GG5
31210.390.7418empty
4900.380.7619empty
5500.260.7316empty

Modifications

Observed in the structure: 1 modified (artifact).

Compared structures

  • 4R3C · Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.